INTRA

2025

1. An International, Expert-Based Delphi Consensus Document on Controversial Issues about TransCarotid Artery Revascularization (TCAR)

   Annals of Vascular Surgery, Vol. 110, pp. 42-53

2. Antithrombotic prophylaxis use and incidence of venous thromboembolism in lung cancer surgery: An observational retrospective study

   Cirugia Espanola, Vol. 103, Núm. 4, pp. 195-200

3. BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203

   Journal of Clinical Oncology, Vol. 43, Núm. 25, pp. 2806-2815

4. Comparative Validation of Risk Assessment Models for Venous Thromboembolism Risk in Hospitalized Medical Patients: Insights from a Multicenter Prospective Cohort Study

   American Journal of Medicine, Vol. 138, Núm. 8, pp. 1150-1158.e1

5. Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE

   Research and Practice in Thrombosis and Haemostasis, Vol. 9, Núm. 8

6. Derivation and Validation of a COPD-specific Pulmonary Embolism Diagnostic Strategy

   Thrombosis and Haemostasis

7. Development of a practice-based score to predict extended duration of proton beam therapy session in pediatric patients

   Clinical and Translational Oncology

8. Dieta en glucogenosis

   Nutrición y dietética clínica (Elsevier), pp. 401-410

9. Differences in the Outcome of Cancer-Associated Thrombosis Depending on Cancer Type

   Thrombosis and Haemostasis, Vol. 125, Núm. 11, pp. 1053-1059

10. Direct Oral Anticoagulants versus Standard Therapy in Upper Extremity Deep Vein Thrombosis: Real-World Evidence

    Thrombosis and Haemostasis

11. Early and certain Ménière’s disease characterization of predictors of endolymphatic hydrops

    Frontiers in Neurology, Vol. 16

12. Editor's corner. Year of transition

    Nutricion Hospitalaria

13. Erratum: BO-112 Plus Pembrolizumab for Patients With Anti–PD-1–Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203 (Journal of Clinical Oncology (2025) DOI: 10.1200/JCO-24-02595)

    Journal of Clinical Oncology

14. First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma

    Neuro-Oncology Advances, Vol. 7, Núm. 1

15. Functional Audiometric Dissociation in Ménière’s Disease: Exploring the Mismatch Between Pure-Tone Thresholds and Speech Recognition

    Journal of Clinical Medicine, Vol. 14, Núm. 13

16. IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

    Cancer research communications, Vol. 5, Núm. 9, pp. 1690-1700

17. Impact of Baseline Thrombocytopenia on Early Outcomes in Patients With Acute Venous Thromboembolism

    American Journal of Hematology, Vol. 100, Núm. 3, pp. 375-382

18. Intercomparison of personal and ambient neutron detectors used for radiation protection in a synchrotron-based proton therapy facility: experimental and Monte Carlo results

    Physica Medica, Vol. 136

19. Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort

    Cancer, Vol. 131, Núm. 16

20. Neutron detectors in proton therapy: Calibration, operational in situ verification, and comparison with Monte Carlo simulation

    Radiation Physics and Chemistry, Vol. 228